Emollient Use and Adjunctive Management in Infant Atopic Dermatitis

Emollient Selection

Thick ointments or petroleum‑based products (e.g., petroleum jelly) applied liberally at least twice daily, immediately after bathing, and formulated without fragrance are recommended for infants with atopic dermatitis; urea‑containing emollients at ≥10 % should be avoided except for limited use on palms and soles. 1
Ointments or thick creams are preferred over lotions because they provide greater occlusion and skin‑penetration, which is essential for effective barrier restoration. 1
Urea‑containing emollients ≥10 % are contraindicated in children younger than 1 year (except once‑daily limited‑area use); after age 2 years, concentrations of 10–20 % may be employed more liberally for their keratolytic and hydrating effects. 1

Apply emollients at least twice daily; for moderate‑to‑severe disease, increase frequency to 3–4 applications per day. 1
Apply the product within 3 minutes of gently patting the skin dry after a bath to trap moisture while the epidermis is maximally hydrated. [1][2]
Use a liberal amount of product to fully cover affected areas; the “liberal and frequent” principle ensures adequate skin surface coverage in infants. 1

Bath in warm (not hot) water for ≥10 minutes using a neutral‑pH, fragrance‑free, hypoallergenic cleanser or a non‑soap cleanser to preserve natural lipids. 2
A dispersible cream can be used as a soap substitute to cleanse without disrupting the skin barrier. 2
Immediate post‑bath emollient application creates a surface lipid film that reduces evaporative water loss, the primary mechanism by which moisturizers improve atopic dermatitis. 2

Regular emollient use provides both short‑ and long‑term steroid‑sparing effects in mild‑to‑moderate atopic dermatitis and can improve barrier function. 3
Continue aggressive emollient therapy even when lesions appear controlled; this constitutes the cornerstone of maintenance treatment. 1
Maintain emollient application throughout any topical corticosteroid course to maximize documented steroid‑sparing benefits. 1

Oral antihistamines are recommended as adjunctive therapy to reduce nighttime itching in atopic dermatitis. 3
Sedating antihistamines (e.g., diphenhydramine, hydroxyzine) should be given only at bedtime for severe nocturnal pruritus, with benefit derived from their sedative effect rather than direct anti‑pruritic action. 1
Non‑sedating antihistamines have no proven value in eczema and should not be used. 1

Topical antihistamines are not recommended; evidence is insufficient for efficacy and they may increase the risk of contact dermatitis. 3
Avoid hot water and regular soaps, as they strip natural skin lipids and exacerbate dryness. [1][2]

If disease control is not achieved with emollients alone, initiate topical corticosteroids as first‑line therapy for flare‑ups; pediatric formulations should be less potent than adult equivalents. 3
Limit the duration of potent topical corticosteroids on sensitive areas (face, neck, skin folds) to prevent skin atrophy. 3
For children aged ≥2 years with inadequate response to appropriate‑strength corticosteroids and emollients, introduce topical calcineurin inhibitors as the next therapeutic step. 4

Oral antihistamines may be used as adjunctive treatment to lessen nighttime itching in children with atopic dermatitis, although their benefit is primarily due to sedation rather than direct anti‑pruritic effects. 5

Topical antihistamine preparations are not recommended because current evidence does not support efficacy and they increase the risk of contact dermatitis. 5
In children with a history of seizures, certain antihistamines should be avoided: ketotifen is contraindicated in epilepsy, and convulsive events have been reported with cyproheptadine, chlorpheniramine, and loratadine. 5

Bleach baths should not be performed in infants unless there are clear clinical signs of bacterial superinfection (e.g., crusting, weeping, pustules); even then, clinicians must carefully weigh potential benefits against the risk of skin irritation. 5

Long‑term topical antibiotics are discouraged because they promote antimicrobial resistance and increase the likelihood of sensitization. 5
Systemic antibiotics should be reserved for cases with documented bacterial infection; they are not indicated for routine management of atopic dermatitis. 5